UNSPSC 51383101: Bermoprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C18H16O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CWU66767HF, chemically known as 10,11-dihydro-alpha,8-dimethyl-11-oxo-dibenz(b,f)oxepin-2-acetic acid but generally known as bermoprofen, which bears US NIH Compound Identifier 54204. European Medicines Agency schedules Bermoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05782MIG.

UNSPSC 51383101 Bermoprofen is a Commodity code for a specific pharmaceutical product, yet the recent state and local procurement activity tagged under this code does not reflect purchases of Bermoprofen itself. Instead, Seminole County, Florida released an IFB in June 2026 (due July 26, 2023) for Naloxone and Safe Drug Deactivation Systems — opioid-reversal medications and harm-reduction equipment wholly unrelated to Bermoprofen's therapeutic class. The mismatch between the code's nominal scope and the actual work being solicited suggests either a misclassification in the county's procurement system or that Bermoprofen purchasing does not generate regular state and local contract opportunities in the current market. Based on the available opportunities block, this code shows no relevant recent activity for Bermoprofen procurement.

The sole recent opportunity under this code illustrates the tagging gap: Seminole County's Naloxone procurement (IFB 60459723LAS) sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with electronic bidding through the county's e-Procurement Portal and a fixed-fee award structure. The contract included a two-year initial term with one-year renewal option, workers' compensation and commercial general liability insurance requirements, E-Verify compliance, and potential FEMA funding tied to federal environmental regulations. Business development professionals should treat this code as inactive for Bermoprofen positioning; the single recent opportunity reflects a system classification error rather than genuine market demand under this commodity designation.